Isthmus Partners
CLB icon

Isthmus Partners’s Core Laboratories CLB Stock Holding History

Isthmus Partners’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$211K Buy
21,804
+981
+5% +$11.4K 0.02% 222
2026
Q2 		$243K Buy
20,823
+6,314
+44% +$90.1K 0.02% 209
2026
Q1 		$244K Buy
14,509
+2,027
+16% +$36.3K 0.03% 205
2025
Q4 		$200K Buy
12,482
+334
+3% +$4.97K 0.02% 212
2025
Q3 		$150 Buy
12,148
+256
+2% +$3K ﹤0.01% 175
2025
Q2 		$137K Buy
11,892
+424
+4% +$5.03K 0.02% 216
2025
Q1 		$172K Buy
11,468
+249
+2% +$4.17K 0.02% 210
2024
Q4 		$194K Buy
11,219
+599
+6% +$11.6K 0.02% 215
2024
Q3 		$197K Buy
+10,620
New +$213K 0.02% 194

Other funds holding CLB

Ariel Investments
Ariel Investments Chicago, Illinois $9.6B AUM 22.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $25.4B AUM 35.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
GJL
Gendell Jeffrey L $9.6B AUM 75.6% 1-Year Est. Return
Heartland Advisors
Heartland Advisors Milwaukee, Wisconsin $2.08B AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Isthmus Partners's CLB Position: Q3 2026 in Review

Isthmus Partners increased its Core Laboratories (CLB) stake by 4.7% in Q3 2026, buying an estimated $11.4K and bringing the position to 21,804 shares worth $211K. The position accounts for 0.02% of the portfolio, ranked #222.

Isthmus Partners first reported a position in CLB in Q3 2024 and has held it in 9 quarters since. The position peaked at $244K in Q1 2026. 131 funds tracked by Wall St. Rank hold CLB as of Q3 2026.

  • Isthmus Partners held 21,804 shares of Core Laboratories worth $211K as of Q3 2026.
  • Isthmus Partners bought 981 Core Laboratories shares in Q3 2026, an estimated $11.4K.
  • Core Laboratories made up 0.02% of Isthmus Partners's portfolio in Q3 2026, its #222 holding.
  • Isthmus Partners first reported a position in Core Laboratories in Q3 2024 and has held it in 9 quarters since.
  • Isthmus Partners's Core Laboratories position peaked at $244K in Q1 2026.
  • 131 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2026.

Based on Isthmus Partners's 13F filing for Q3 2026, filed 21 Oct 2026.